|
|
Clinical significance of Ankyrin repeat domain 12 expression in colorectal cancer
|
|
|
|
|
نویسنده
|
bai r. ,li d. ,shi z. ,fang x. ,ge w. ,zheng s.
|
منبع
|
journal of experimental and clinical cancer research - 2013 - دوره : 32 - شماره : 1
|
چکیده
|
Background: ankyrin repeat domain 12 (ankrd12),is encoding a 224 kda nuclear protein and most conserved at its n-terminal ankyrin repeats region and the c-terminal co-activator interacting domain. the aim of this study was to investigate the ankrd12 mrna expression in colorectal cancer (crc) tumor tissues and the normal adjacent mucosa and its potential relevance to clinicopathological characteristics and prognosis. methods. surgical specimens of tumor tissues (n = 68) and adjacent normal mucosa (n = 51) were obtained from crc patients. the ankrd12 mrna expression was measured by quantitative real time reverse transcriptase polymerase chain reaction. the relationship between ankrd12 mrna expression and clinicopathological features was analyzed by appropriate statistics. kaplan-meier analysis and cox proportional hazards regression models were used to investigate the correlation between ankrd12 expression and prognosis of crc patients. results: the relative mrna expression of ankrd12 were significantly lower in crc tumor tissues than in the normal adjacent mucosa (p < 0.001),and the cases with low ankrd12 expression showed a higher frequency of liver metastasis (p = 0.015). kaplan-meier analysis indicated that patients (crc without liver metastasis) with low ankrd12 expression had poor overall survival (p = 0.041). multivariate analysis showed that low ankrd12 expression was an independent predictor of overall survival. conclusion: this study revealed that ankrd12 mrna were down regulated in crc tumor tissues and low ankrd12 expression was correlated with liver metastasis and poor survival of crc patients. © 2013 bai et al.; licensee biomed central ltd.
|
کلیدواژه
|
Ankyrin repeat domain 12 (ANKRD12); Colorectal cancer; Metastasis; Prognostic factor
|
آدرس
|
cancer institute,second affiliated hospital,zhejiang university school of medicine,88 jiefang road,hangzhou,zhejiang,china,key laboratory of cancer prevention and intervention,china national ministry of education,hangzhou,zhejiang,china,department of medical oncology,hangzhou first people's hospital,hangzhou cancer hospital,hangzhou,zhejiang, China, cancer institute,second affiliated hospital,zhejiang university school of medicine,88 jiefang road,hangzhou,zhejiang,china,key laboratory of cancer prevention and intervention,china national ministry of education,hangzhou,zhejiang, China, cancer institute,second affiliated hospital,zhejiang university school of medicine,88 jiefang road,hangzhou,zhejiang,china,key laboratory of cancer prevention and intervention,china national ministry of education,hangzhou,zhejiang, China, cancer institute,second affiliated hospital,zhejiang university school of medicine,88 jiefang road,hangzhou,zhejiang,china,key laboratory of cancer prevention and intervention,china national ministry of education,hangzhou,zhejiang,china,department of medical oncology,second affiliated hospital,zhejiang university school of medicine,hangzhou,zhejiang, China, cancer institute,second affiliated hospital,zhejiang university school of medicine,88 jiefang road,hangzhou,zhejiang,china,key laboratory of cancer prevention and intervention,china national ministry of education,hangzhou,zhejiang, China, cancer institute,second affiliated hospital,zhejiang university school of medicine,88 jiefang road,hangzhou,zhejiang,china,key laboratory of cancer prevention and intervention,china national ministry of education,hangzhou,zhejiang, China
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|